Brief: Qiagen And Myriad Genetics Partner To Advance Development Of Companion Diagnostics For Cancer

Qiagen NV

26/10/2023 13:09

Oct 26 (Reuters) - QIAGEN NV  QIA.DE :
    * QIAGEN AND MYRIAD GENETICS PARTNER TO ADVANCE DEVELOPMENT
OF
COMPANION DIAGNOSTICS FOR CANCER

Source text for Eikon:  ID:nGNE2ZYl3T 
Further company coverage:  QIA.DE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))